THE US Food and Drug Administration (FDA) has heightened its warning level about homeopathic teething products (PD 04 Oct), formally advising that tablets containing belladonna pose an unnecessary risk to infants.
FDA laboratory analysis has found "inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label," according to an urgent update issued over the weekend.
In light of the findings the FDA has contacted the manufacturer of Hyland's homeopathic teething products, Los Angeles-based Standard Homeopathic Company, regarding a recall of the items.
"At this time, the company has not agreed to conduct a recall," the FDA said, with the agency instead now formally recommending consumers stop using the Hyland's products and dispose of any tablets in their possession.
Three months ago the Australian Therapeutic Goods Administration also advised it was conducting urgent laboratory testing of homeopathic teething products currently marketed in Australia (TD 21 Oct), to ascertain whether any action is required here.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jan 17
